SEC Form 4 · accession 0001354488-17-000570
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cora M Tellez
Director
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 30, 2017 | P | 7,550 | $0.415 | A | 182,371 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 20,714 | 20,714 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 3,472 | 3,472 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to Buy Common Stock)F5 | $2.05 | holding | — | — | — | — | Apr 3, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (Right to Buy Common Stock)F2 | $5.62 | holding | — | — | — | — | Mar 1, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 4,205 | 4,205 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 2,873 | 2,873 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 1,371 | 1,371 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 2,868 | 2,868 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 3,645 | 3,645 | D |
| Stock Option (Right to Buy Common Stock)F2 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 100,000 | 100,000 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 4,104 | 4,104 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 15,306 | 15,306 | D |
Explanation of responses
- F1The purchase was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on August 19, 2016.
- F2These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F4Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F5The options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant, and 1/3 on the second anniversary of the date of grant.